Replication capacities of chimeric NL4-3 encoding gag-protease from recent HIV-1 isolates are significantly reduced compared to those derived from isolates.

Slides:



Advertisements
Similar presentations
Emerging patterns of drug resistance and viral tropism in cART-naïve and failing patients infected with HIV-1 subtype C Thumbi Ndung’u, BVM, PhD Associate.
Advertisements

Evoluzione genetica di HIV ed evoluzione clinica della malattia AIDS: due aspetti correlati? Carlo Federico Perno.
Epistatic effect and positive selection in the HIV-1 vif gene are linked with APOBEC3G/F neutralization activity Élcio Leal 1, Shiori Yabe 3, Hirohisa.
“ The therapeutic effect of FIT- 06, GTU®-Multi-HIVB DNA vaccine, observed in HIV-1 infected people. Results of a Phase II trial”. Prof. Mart Ustav SVP,
Antiviral Immunity and Transmission June 19, 2011 Abst. #: TUAA0105 Maraviroc-resistant subtype B primary HIV-1 induced in vitro selection became highly.
Bioe 109 Evolution Summer 2009 Lecture 1: Part II Evolution in action: the HIV virus.
Mol Biol Evol 2007 Vol 24: Which adaptations to human characterize the transfer from SIVcpz to HIV-1?
Phase 2 of new ARVs BMS (maturation inhibitor)
Virus Evolution Molecular Epidemiology of Viral Infections Jen-Ren Wang, Ph. D. 王貞仁 Dept. of Medical Laboratory Science and Biotechnology National Cheng.
Materials and Methods Abstract Conclusions Introduction 1. Korber B, et al. Br Med Bull 2001; 58: Rambaut A, et al. Nat. Rev. Genet. 2004; 5:
Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.
Immune correlates of unusual control of viral replication after cessation of HAART Ellen Van Gulck 1, Leo Heyndrickx 1, Céline Merlin 1, Sandra Coppens.
The Influence of CCL3L1 Gene- Containing Segmental Duplications on HIV-1/AIDS Susceptibility Gonzalez et al. Mar 4, 2005 :307 Science Presenter: Braydon.
Experimental Virology HIV in Eastern Europe / Central Asia Epidemiological, virological and sociological factors associated with the transition from a.
Characteristics of transmitted viruses in acute and early HIV infection Eric Hunter IAC 2010.
Phylogenetic Insight into HIV Transmission Networks in a Southeastern US Cohort Ann Dennis 1, Stéphane Hué 2, Christopher Hurt 1, Sonia Napravnik 1, Deenan.
Safety and effect of an extract from Ganoderma lucidum (Reishi) on NK cell numbers in HIV+ individuals not taking antiretroviral therapy. JT Leonard 1,
Phagocyte. B cells Receptor B Cell Naïve B cell B cells and antibodies daughter cells produce antibodies phagocyte consumes an antibody coated virus.
HIV-1 evolution in response to immune selection pressures
The evolution of HIV Why is HIV fatal?. Lethal strains are favored, due to “Short sighted” evolution within hosts Transmission rate advantages.
HIV Cellular Pathogenesis III
Examining Subjects of HIV-1 With Possible Predominant Viral Strains Samantha Hurndon Isaiah Castaneda.
HIV-1 TRANSMISSION FROM SEMEN TO CERVICO-VAGINAL TISSUE EX VIVO Andrea Introini 1, Christophe Vanpouille 1, Andrea Lisco 1, Jean-Charles Grivel, Arshi.
Phylogenetic analysis of HIV-1 Gag cleavage sites polymorphism in HIV acutely infected patients Castro E 1,2, Cavassini M 1, Bart PA 2 and Pantaleo G 2.
Protease Polymorphisms in HIV-1 Subtype CRF01_AE Represent Selection by Antiretroviral Therapy and Host Immune Pressure Weerawat Manosuthi 1,2, David M.
Characterization of persistent HIV-1 in a broad spectrum of CD4 + T-cells isolated from peripheral blood, bone marrow, lymphoid tissue and gut associated.
HIV-1 infected subjects treated with an autologous dendritic cell therapy (AGS-004), exhibited a significant reduction in viral load (when compared to.
Using Molecular Information to Investigate the Evolutionary Origin of the HIV Virus.
HIV/ AIDS Right now, 1 out of every 300 people in the United States has HIV, the virus that causes AIDS.
Project 1: Anti-HIV Mechanisms of NK-1R Antagonists PI: Wenzhe Ho Co-PI: Steven D. Douglas.
Persistent HIV-1 infection in duodenal mucosa and memory CD8+ T cell differentiation Liliana Belmonte 1 PhD; Alberto Zalar 2 MD; Patricia Baré 1 PhD; Noel.
Intersubtype differences in the effect of a rare p24 Gag mutation on viral replicative fitness Denis Chopera.
HIV & AIDS BY DR. MOHAMMED ARIF HEAD OF THE VIROLOGY UNIT ASSOCIATE PROFESSOR & CONSULTANT VIROLOGIST.
Determinants of HIV Transmission Eric Hunter Emory Vaccine Center.
HIV Cellular Pathogenesis III Benhur Lee, M.D.. Adult v. infant (IgG v. IgA) CTL response (MHC tetramers) p24 antigenimia Ab response Viral load.
ANIMAL MODELS FOR HIV VACCINES Girish N. Vyas, Ph.D. UCSF School of Medicine, San Francisco (UCSF) A quote from the keynote Address at the January, 2008.
REASSORTMENT OF INFLUENZA VIRUS
HIV-1 infection decreases CD127 and PD1 expression on duodenal CD8+T cells Liliana Belmonte, PhD Academia Nacional de Medicina Buenos Aires, Argentina.
Patterns of selection for or against amino acid change among different CD4 T-cell count progressor groups Michael Pina, Salomon Garcia Journal Club Presentation.
Assay To Measure The Latent Reservoir Of Replication-Competent HIV-1 In Suppressed Patients Based On Ultra Deep Sequencing Sook-Kyung Lee.
Examining Subjects of HIV-1 With Possible Predominant Viral Strains Samantha Hurndon Isaiah Castaneda.
ImmunoPathogenesis of HIV Disease Overview of HIV Epidemic Basic biology of HIV-1 Stages of HIV Disease Viral and Cellular Dynamics after HAART HIV Therapy.
HIV/AIDS.
Examining the Genetic Similarity and Difference of the Three Progressor Groups at the First and Middle Visits Nicole Anguiano BIOL398: Bioinformatics Laboratory.
Examining Genetic Similarity and Difference of the Three Progressor Groups at the First and Middle Visits Nicole Anguiano Bioinformatics Laboratory Loyola.
CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.
Evolution and transmission in HIV Steve Paterson Review; Rambaut 2004 Nature Reviews Genetics 5: ‘The causes and consequences of HIV evolution’
Examining Genetic Similarity and Difference of the Three Progressor Groups at the First and Middle Visits Nicole Anguiano BIOL398: Bioinformatics Laboratory.
Evolution: rate of evolution CfE Advanced Higher Biology Unit 2: Organisms and Evolution.
Impact of immune-driven sequence variation in HIV- 1 subtype C Gag-protease on viral fitness and clinical outcome Thumbi Ndung’u, BVM, PhD HIV Pathogenesis.
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A,
Prof. Vivian Kourí, MD, PhD Institute of Tropical Medicine Pedro Kourí, Havana, Cuba. HIV-1 viral variants circulating in Cuba. Implications for disease.
Viral evolution and adaption
HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK
Partners AIDS Research Center Massachusetts General Hospital
Volume 65, Issue 1, Pages S2-S21 (October 2016)
Chronic immune activation in HIV associated Non Hodgkin lymphoma and the effect of antiretroviral therapy Brian Flepisi University of the Western Cape.
Preparation of plasmids containing HBV-full genome of genotype A to H and trial of HBV inactivation method Yoshiaki Okada Kiyoko Umemori Kazunari.
Viral Genetics.
Hiv.
Didier Trono, Flavia Marzetta  Cell Host & Microbe 
مدیریت امور آزمایشگاهها دانشگاه علوم پزشکی کاشان
Monique Nijhuis University Medical Center Utrecht, the Netherlands
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A,
Frequency and implications of HIV superinfection
HIV-1 Vpu Mediates HLA-C Downregulation
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A,
Evolution and transmission in HIV
Double Trouble: HIV Latency and CTL Escape
Correlation of HIV-1 replication fitness, as measured by the Monogram Biosciences RC assay, with baseline CD4+ T-cell count (a) and baseline plasma HIV-1.
Presentation transcript:

Replication capacities of chimeric NL4-3 encoding gag-protease from recent HIV-1 isolates are significantly reduced compared to those derived from isolates in early days of epidemic in Japan Shigeru Nomura, Noriaki Hosoya, Tadashi Kikuchi, Michiko Koga, Hitomi Nakamura, Tomohiko Koibuchi, Takeshi Fujii, Ai Kawana-Tachikawa, Aikichi Iwamoto, Toshiyuki Miura The Institute of Medical Science The University of Tokyo

Backgrounds HIV-1 evolves rapidly, escaping from host selection pressures like CTL response Some CTL escape variants with reduced replication capacities could transmit from one person to another Escape variants accumulate in a population and could replace previously dominant forms Recent isolates may have distinct replication capacity from those from early days of HIV epidemic Objectives To investigate if HIV-1 replication capacity has been changed over the epidemic in Japan

Studied Population 158 treatment naïve Japanese with asymptomatic chronic HIV-1 infection Research Hospital of the University of Tokyo from 1994 to 2009 Sexual Intercourse (85% were MSM) Plasma from near first visit Limited to cladeB infection

Generation of chimeric viruses by homologous recombination RT-PCR plasma virus Slope of GFP expression gag- pro LTR-driven GFP reporter T cell line ⊿ gag-pro pNL4-3 gag- pro infection Measure % of GFP expression Methods Sequencing and subtyping

No correlation between pVL, CD4+ T cell count and first visit year r=0.035 p=0.33 r=0.040 p=0.70 pVLCD4

JP US CN NL4-3 N = 55 within a cluster in the phylogenetic tree rp value year ** CD4-2.0e log pVL ** r = p = ** CD4 T cell counts > 200 /  l, n = 145 (n=22) CD4 >500/μlCD4 >300/μl (n=101) stratified by CD4+ T cell count Correlation between VRC and first visit year

Conclusions and Limitations Recent HIV-1 circulating in Japan may have reduced In vitro replication capacity Investigation was limited to Gag-protease Backbone of chimeric viruses: –NL4-3 is an early laboratory strain 15 years may be too short